OLMA — Olema Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $614.23m
- $156.16m
Brief: Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Olema Oncology Announces New Clinical Trial Agreement With Pfizer To Combine Palazestrant With Atirmociclib In Er+/Her2- Metastatic Breast Cancer
U.S. RESEARCH ROUNDUP- Advanced Drainage Systems, Assurant, Chipotle Mexican Grill
Olema Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Olema Pharma Q2 net loss widens to $43.8 mln
Olema Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Olema Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule
Olema Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Olema Oncology Q1 Net Income USD -30.389 Million
Olema Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Olema Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Olema Oncology Q4 Net Income USD -33.567 Million
Olema Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview
Brief: Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Olema Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart
Brief: Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136